# US 2022/0031916 A1 · Zn-ga series alloy and its preparation method and application

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0031916 A1
- Document ID: US20220031916A1
- Status: Published application
- Kind: A1
- Application number: 17/141,609
- Filed: 2021-01-05
- Published: 2022-02-03
- Earliest claimed: 2020-08-03
- Assignees: University of Science and Technology Beijing
- Applicants: University Of Science & Technology Beijing
- Inventors: Huafang Li; Yixing Zheng; Luning Wang
- Web page: https://patentgrep.com/patent/US20220031916A1

## CPC

- A61L 31/022: {Metals or alloys}
- A61B 17/72: Intramedullary devices, e.g. pins or nails
- A61B 17/842: {Flexible wires, bands or straps (A61B17/72, A61B17/82, A61B17/86 take precedence)}
- A61B 17/846: {Nails or pins, i.e. anchors without movable parts, holding by friction only, with or without structured surface (A61B17/72, A61B17/86 take precedence)}
- A61B 17/86: Pins or screws {or threaded wires; nuts therefor (A61B17/72 take precedence)}
- A61F 2/04: Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts (A61F2/18, A61F2/20 take precedence; instruments specially adapted for placement or removal of stents or stent-grafts A61F2/95)
- A61F 2/06: Blood vessels
- A61L 31/086: {Phosphorus-containing materials, e.g. apatite}
- A61L 31/088: {Other specific inorganic materials not covered by A61L31/084 or A61L31/086}
- A61L 31/10: Macromolecular materials
- A61L 31/148: {Materials at least partially resorbable by the body}
- A61L 31/16: Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}
- C22C 18/00: Alloys based on zinc
- C22F 1/165: {of zinc or cadmium or alloys based thereon}
- A61B 17/58: for osteosynthesis, e.g. bone plates, screws or setting implements (A61B17/14, A61B17/16 take precedence)
- A61B 17/866: {Material or manufacture}
- A61F 2/02: Prostheses implantable into the body
- A61F 2/28: Bones
- A61F 2/82: Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents (stent-grafts for tubular structures of the body other than blood vessels A61F2/04; stent-grafts for blood vessels A61F2/07)
- A61F 2002/041: {Bile ducts}
- A61F 2002/044: {Oesophagi or esophagi or gullets}
- A61F 2002/045: {Stomach, intestines}
- A61F 2002/046: {Tracheae}
- A61F 2002/047: {Urethrae}
- A61F 2002/2889: {Maxillary, premaxillary or molar implants}
- A61F 2240/001: Designing or manufacturing processes
- A61F 2250/0067: Means for introducing or releasing pharmaceutical products into the body
- A61L 2300/204: with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
- A61L 2300/216: with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
- A61L 2300/404: Biocides, antimicrobial agents, antiseptic agents
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- C22C: ALLOYS (treatment of alloys C21D, C22F)
- C22F: CHANGING THE PHYSICAL STRUCTURE OF NON-FERROUS METALS AND NON-FERROUS ALLOYS (surface treatment of metallic material involving at least one process provided for in class C23 and at least one process covered by this subclass, C23F17/00)

## Abstract

The invention discloses a Zn—Ga series alloy and a preparation method and application thereof, belonging to the technical field of medical alloys. The Zn—Ga series alloy includes Zn and Ga, and Ga accounts for 0-30 wt % but not including 0. The preparation method is to mix Zn and Ga or Zn, Ga and trace elements, then to obtain a Zn—Ga series alloy by coating paint after smelting or sintering. The mechanical properties of the prepared Zn—Ga series alloy meet the requirements of the strength and toughness of medical implant materials, and it can be degraded in vivo. It has the dual characteristics of biological corrosion degradation and suitable corrosion rate to provide long-term effective mechanical support.

## Claims

### Claim 1

A Zn—Ga series alloy is characterized in that it comprises Zn and Ga, and Ga accounts for 0-30 wt %, but not including 0.

### Claim 2 (depends on 1)

The Zn—Ga series alloy according to claim 1 is characterized in that the Zn—Ga series alloy further includes trace elements, which is at least one of magnesium, calcium, strontium, manganese, titanium, zirconium, germanium, copper, silicon, phosphorus, lithium, silver, tin and rare earth elements.

### Claim 3 (depends on 2)

The Zn—Ga series alloy according to claim 2 is characterized in that the trace element accounts for 0-10 wt %.

### Claim 4 (depends on 1)

The Zn—Ga series alloy according to claim 1 is characterized in that the surface of the Zn—Ga series alloy is further coated with a degradable polymer coating, a degradable ceramic coating or a degradable drug coating.

### Claim 5 (depends on 1)

The Zn—Ga series alloy according to claim 1 is characterized in that the preparation material of the degradable polymer coating is at least one of the following 1) and 2):
1) any one of polycaprolactone, polylactic acid, polyglycolic acid, L-polylactic acid, polycyanoacrylate, polyanhydride, polyphosphazene, polydioxanone, polyhydroxybutyrate and polyhydroxyvalerates;
2) a copolymer of any two or more of polylactic acid, polycaprolactone, polyglycolic acid, L-polylactic acid, polycyanoacrylate, and polydioxanone;
the preparation material of the ceramic coating is at least one of hydroxyapatite, tricalcium phosphate or tetracalcium oxyphosphate;
the drug coating is at least one of rapamycin and its derivative coatings, paclitaxel coatings, everolimus coatings, sirolimus coatings, mitomycin coatings and antibacterial coatings.

### Claim 6 (depends on 1)

A method for preparing a Zn—Ga series alloy according to claim 1 is characterized in that it comprises the following steps:
Mix Zn, Ga and the trace elements according to any one of the following methods 1) and 2) to obtain a mixture.
1) Zn and Ga;
2) Zn, Ga and trace elements;
the zinc alloy can be obtained according to the following steps a) or b).
a) under the protection of CO2 and SF6 atmosphere, the mixture is smelted or sintered, and the zinc alloy is obtained after cooling;
b) under the protection of CO2 and SF6 atmosphere, the mixture is smelted or sintered, and the degradable polymer coating, the degradable ceramic coating or the degradable drug coating is coated after cooling to obtain the Zn—Ga series alloy.

### Claim 7 (depends on 6)

The method for preparing the Zn—Ga series alloy according to claim 6 is characterized in that it further comprises a step of machining the Zn GA series alloy.

### Claim 8 (depends on 7)

The method for preparing a Zn—Ga series alloy according to claim 7 is characterized in that the mechanical processing is at least one of rolling, forging, rapid solidification and extrusion.

### Claim 9 (depends on 6)

The method for preparing a Zn—Ga series alloy according to claim 6 is characterized in that the sintering is any one of the following methods—element powder mixed sintering method, pre-alloyed powder sintering method, and self-propagating high-temperature synthesis method.

### Claim 10 (depends on 1)

An application of the Zn—Ga series alloy according to claim 1 is characterized in that the Zn—Ga series alloy is used in preparing a body fluid-degradable medical implant.
